US Patent 11447521 Compounds and methods for modulating angiotensinogen expression
Patent 11447521 was granted and assigned to Ionis Pharmaceuticals on September, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 18, 2021
0
Date of Patent
September 20, 2022
0
Patent Applicant
Patent Application Number
17529897
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11447521 Compounds and methods for modulating angiotensinogen expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
